Preclinical biomedical developer of a patented 3D microfluidic membrane that mimics pulmonary blood flow to enable safer, clot‑free artificial lung therapy. Targets hospitals and patients with lung failure to reduce blood damage, anticoagulation needs, complications and costs; validated in vitro and in large-animal models.